Researchers at the University of Oxford will begin studying AbbVie's drug, Humira, as a potential treatment for COVID-19 patients, the university announced Sept. 30.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,